| |
Obese patients (21) |
Matched control (30) |
p - value |
| Variable |
Mean ± SD |
Mean ± SD |
| C16:0 |
31.3 ± 2.1 |
29.4 ± 6.3 |
- |
| C16:1 |
0.5 ± .20 |
1.9 ± 1.8 |
< .001 |
| C18:0 |
14.5 ± 1.4 |
16.9 ± 5.3 |
0.03 |
| C18:1 |
15.5 ± 0.8 |
21.3 ± 3.2 |
< .001 |
| SFA |
45.8 ± 1.4 |
46.3 ± 9.3 |
- |
| MUFA |
16.0 ± 0.8 |
23.0 ± 4.5 |
< .01 |
| C18:2 |
12.0 ± 1.1 |
10.4 ± 3.0 |
0.02 |
| C20:3 |
2.0 ± .4 |
1.4 ± 1.0 |
0.008 |
| C20:4 |
17.4 ± 1.6 |
12.9 ± 7.2 |
0.003 |
| C20:5 |
0.5 ± .1 |
0.9 ± 1.1 |
- |
| C22:6 |
4.7 ± 0.8 |
1.7 ± 1.3 |
< .001 |
| n3 PUFA |
5.2 ± 0.9 |
2.6 ± 1.8 |
< .001 |
| n6 PUFA |
31.3 ± 1.7 |
25.0 ± 10.1 |
< .001 |
| Total PUFA |
36.5 ± 1.4 |
27.3 ± 10.9 |
< .001 |
| TC 18:1 |
0.2 ± 0.1 |
0.3 ± 0.3 |
0.07 |
| TC20:4 |
0.03 ± 0.03 |
1.0 ± 1.2 |
< .001 |
| Total TFA |
0.2 ± 0.1 |
1.3 ± 1.2 |
< .001 |
| SFA/MUFA |
2.9 ± 0.2 |
2.1 ± 0.6 |
< .001 |
| C16:1/16:0 |
0.02 ± 0.01 |
0.1 ± 0.1 |
0.002 |
| C18:1/18:0 |
1.1 ± 0.1 |
1.4 ± 0.4 |
< .001 |
| Data are presented as mean ± S.D. Abbreviations: MUFA, monounsaturated fatty acids; SFA, saturated fatty acids; TFA, trans fatty acids |
|
